Noze’s CEO, Karim Aly was interviewed by Robotics & AI News – Unite.AI Karim Aly is CEO of Noze, a Canadian AI startup that has developed the world’s leading technology to digitize the sense of smell. He is focused on executing the company’s vision to transform… Read More »Noze’s CEO, Karim Aly was interviewed by Robotics & AI News – Unite.AI
Our Partner Kelvin Zero Released a White Paper on Digital Solutions to Protect Patient Health Data The human lifespan has doubled since 1800, largely thanks to healthcare improvements – the engine of our society’s well-being. Beyond hospitals, doctors, nurses, and medicine, protected health information (PHI)… Read More »Our Partner Kelvin Zero Released a White Paper on Digital Solutions to Protect Patient Health Data
A New Frontier in Type 2 Diabetes Research and Its Link to Heart Disease Researchers at the Montreal Heart Institute are looking for new treatments to reduce the risk of cardiovascular disease before it happens, and their earlier work has already yielded promising results What… Read More »A New Frontier in Type 2 Diabetes Research and Its Link to Heart Disease
Our partner Noze receives $1M grant from the Bill & Melinda Gates Foundation MONTREAL – March 14, 2023 – Noze (formerly Stratuscent), a Canadian AI startup that has developed the world’s leading technology to digitize the sense of smell, today announced a grant of $1 million… Read More »Our partner Noze receives $1M grant from the Bill & Melinda Gates Foundation
Perceiv AI announces an investment of $1.5M from strategic and institutional investors to support the expansion of its prognostic platform Foresight(TM) Perceiv AI today announced the closing of an investment of $1.5M. Perceiv AI is a precision medicine company optimizing and de-risking clinical trials and enabling physicians… Read More »Perceiv AI announces an investment of $1.5M from strategic and institutional investors to support the expansion of its prognostic platform Foresight(TM)
(THIS ARTICLE IS AVAILABLE EXCLUSIVELY IN FRENCH) Les personnes qui souffrent de maladies rares, ou qui ont des besoins bien particuliers pour leur suivi médical, pourraient voir leurs traitements s’améliorer grâce à l’utilisation de drones. Pour y arriver un jour, le groupe ECOGENE-21, basé à… Read More »ECOGENE-21 tests medication and sample delivery by drone in Alma
As part of our project, our partner ECOGENE-21 has successfully completed the first demonstrations of delivery by drone for clinical trials at the Center of Excellence on Drones in Alma. ECOGENE-21 collaborates with the Montreal Health Innovations Coordinating Center (MHICC) of the Montreal Heart Institute… Read More »ECOGENE-21: Drones to promote access to clinical research
The Montreal Heart Institute improves medical practice with patients and clinicians Dr. Jean Claude Tardif, Director of the Montreal Heart Institute (MHI) Research Center explains how the institute actively participates in research in order to alleviate, cure and prevent certain health problems, and how patients… Read More »The Montreal Heart Institute improves medical practice with patients and clinicians
The Montreal Heart Institute Receives $9.35 Million From the Quebec Government to Lead a Major Virtual Clinical Trial Project The Montreal Heart Institute (MHI) announces that it has won a request for proposals from the Fonds d’accélération des collaborations en santé (FACS). Pierre Fitzgibbon, Minister… Read More »The Montreal Heart Institute Receives $9.35 Million From the Quebec Government to Lead a Major Virtual Clinical Trial Project
Health Collaborations Acceleration Fund – Over $9.3 million awarded to the Montreal Heart Institute and it’s partners to improve clinical trials (THIS ARTICLE IS AVAILABLE EXCLUSIVELY IN FRENCH) MONTRÉAL, le 13 déc. 2021 /CNW Telbec/ – Le ministre de l’Économie et de l’Innovation et ministre responsable… Read More »Health Collaborations Acceleration Fund – Over $9.3 million awarded to the Montreal Heart Institute and it’s partners to improve clinical trials